Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “AstraZeneca”

Prospective, Non-interventional Single-arm Study With Tezepelumab to Investigate the Change in Clinical and Patient-reported Outcomes in Patients With CRSwNP in Real-world (PETRICHOR)Recruiting
NCT07633158N/AUpdated Jul 29, 2026
Sponsor: AstraZeneca
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Germany
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate CancerRecruiting
NCT07192614Phase 1, Phase 2Updated Jul 29, 2026
Sponsor: AstraZeneca
Prostate Cancer
United States, Belgium, Canada, China, Japan +4 more
Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)Active Not Recruiting
NCT05771480Phase 3Updated Jul 29, 2026
Sponsor: AstraZeneca
Biliary Tract Cancer
United States, France, Germany, Italy, Japan +3 more
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum ChemotherapyActive Not Recruiting
NCT01874353Phase 3Updated Jul 29, 2026
Sponsor: AstraZeneca
Platinum Sensitive · BRCA Mutated · Relapsed Ovarian Cancer · Following Complete or Partial Response to Platinum Based Chemotherapy
United States, Australia, Belgium, Brazil, Canada +12 more
Non-alcoholic Steatohepatitis Registry Platform StudyTerminated
NCT06123858N/AUpdated Jul 29, 2026
Sponsor: AstraZeneca
NASH With Fibrosis
China
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)Recruiting
NCT06079671Phase 3Updated Jul 29, 2026
Sponsor: AstraZeneca
Locally Advanced Cervical Cancer
United States, Brazil, Canada, China, Denmark +14 more
Benralizumab Airway Remodeling Study in Severe Eosinophilic AsthmaticsActive Not Recruiting
NCT03953300Phase 4Updated Jul 28, 2026
Sponsor: AstraZeneca
Asthma
United States, Canada, Denmark, Sweden, United Kingdom
A Study of AZD0120 in Autoimmune DiseasesRecruiting
NCT07295847Phase 1Updated Jul 28, 2026
Sponsor: AstraZeneca
Systemic Sclerosis · Idiopathic Inflammatory Myopathies · Rheumatoid Arthritis
United States, Australia, Germany, Spain, Sweden +1 more
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood PressureRecruiting
NCT06742723Phase 3Updated Jul 28, 2026
Sponsor: AstraZeneca
Chronic Kidney Disease and Hypertension
United States, Argentina, Australia, Belgium, Brazil +37 more
Efficacy and Safety of 80mg Osimertinib in Patients With Non-small Cell Lung Cancer(NSCLC)Completed
NCT04563871Phase 2Updated Jul 28, 2026
Sponsor: Sehhoon Park
Non-small Cell Lung Cancer (NSCLC)
South Korea
Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney DiseaseRecruiting
NCT07228364Phase 1Updated Jul 28, 2026
Sponsor: AstraZeneca
Autosomal Dominant Polycystic Kidney Disease
United States, China, United Kingdom
A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.Active Not Recruiting
NCT05984277Phase 3Updated Jul 28, 2026
Sponsor: AstraZeneca
Metastatic Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +20 more
Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)Recruiting
NCT05454787N/AUpdated Jul 28, 2026
Sponsor: AstraZeneca
Life Threatening Bleeding · Factor Xa Inhibitor
Japan
A Phase I, Cross-over Study Comparing the Relative Bioavailability of Laroprovstat Plus Ezetimibe Fixed Combination Drug Products Versus Their Single Therapy Products in Healthy AdultsActive Not Recruiting
NCT07622433Phase 1Updated Jul 28, 2026
Sponsor: AstraZeneca
Healthy Participants
United States
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural MesotheliomaActive Not Recruiting
NCT06097728Phase 3Updated Jul 28, 2026
Sponsor: AstraZeneca
Unresectable Pleural Mesothelioma
United States, Australia, Belgium, Brazil, Canada +16 more
Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLCActive Not Recruiting
NCT03141359Phase 2Updated Jul 28, 2026
Sponsor: Wake Forest University Health Sciences
Lung Cancer Stage II · Lung Cancer Stage III · Non Small Cell Lung Cancer
United States
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial CancerRecruiting
NCT07022483Phase 3Updated Jul 28, 2026
Sponsor: Daiichi Sankyo
Endometrial Cancer
United States, Argentina, Chile, China, France +8 more
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsRecruiting
NCT06218914Phase 1Updated Jul 28, 2026
Sponsor: AstraZeneca
Non-small Cell Lung Cancer · Colorectal Carcinoma · Pancreatic Ductal Adenocarcinoma · Endometrial Cancer
United States
An Open-label Study of AZD0120 in Adults With Multiple SclerosisRecruiting
NCT07224373Phase 1Updated Jul 27, 2026
Sponsor: AstraZeneca
Multiple Sclerosis
United States, Australia, Canada, Germany, United Kingdom
A Study to Investigate the Effect of Capivasertib on the Pharmacokinetics of Oral Dextromethorphan (CYP2D6 Substrate) in Healthy ParticipantsCompleted
NCT07241065Phase 1Updated Jul 27, 2026
Sponsor: AstraZeneca
Healthy Participants
Germany
The Phase 1, Open-label, PET Trial Designed to Investigate the Effect of AZD2389 on FAP Occupancy in the Liver in Participants With Advanced Liver Fibrosis.Completed
NCT07069725Phase 1Updated Jul 27, 2026
Sponsor: AstraZeneca
Liver Fibrosis · Hepatic Cirrhosis
Sweden
Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung CancerActive Not Recruiting
NCT04612751Phase 1Updated Jul 27, 2026
Sponsor: AstraZeneca
Advanced or Metastatic NSCLC
United States, Belgium, Italy, Japan, Poland +3 more
Fasenra Pediatric Japan Post-Marketing Study(PMS)Active Not Recruiting
NCT06427876N/AUpdated Jul 27, 2026
Sponsor: AstraZeneca
Bronchial Asthma
Japan
MONTEROSA - Italian Multicenter Observational Study to Evaluate Time to Clinical Hepatic Decompensation, Quality of Life, Effectiveness, and Safety of Tremelimumab Plus Durvalumab in Patients With Advanced or Unresectable Hepatocellular Carcinoma Who Have Received no Prior Systemic Treatment.Recruiting
NCT07607769N/AUpdated Jul 27, 2026
Sponsor: AstraZeneca
Hepatocellular Carcinoma
Italy
Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.Active Not Recruiting
NCT05267613Phase 3Updated Jul 27, 2026
Sponsor: AstraZeneca
Erosive Esophagitis
United States, Argentina, Australia, Belgium, Greece +5 more

Previous page Next page